Part of Middle East Respiratory Syndrome
1 published article · Updated continuously
16 trials tracked for coronavirus infection: 3 in phase 3 or 4 and 2 with published results. The most-cited published study has 55 citations.
Showing the 16 most-cited and recently-updated of 16 trials. Browse the full registry →
Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.
Convalescent plasma has been evaluated in multiple trials for the treatment of coronavirus infection. One Phase 3 trial included convalescent plasma as an intervention 1. In a Phase 2 study, convalescent plasma was associated with a reduction in ventilator days (15.6 vs. 4.2) and a higher rate of normal chest X-rays at 28 days (9 vs. 3) 8. Another Phase 2 trial evaluating convalescent plasma showed no significant difference in clinical improvement scores on the WHO 11-point Ordinal Scale at either 14 or 28 days 9.
The BCG vaccine was evaluated in a Phase 4 study for coronavirus infection 2.
AI synthesis of 5 cited trials, updated Jun 29, 2026. Informational only — not medical advice; trial data sourced from ClinicalTrials.gov. How we use AI.
